HuGE Literature Finder
Records
1
-
8
| Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism. Molecular genetics & genomic medicine 2019 Jul e871. He Yaning, Liu Hui, Chen Qi, Shao Yingbo, Luo Sux |
| Functional IGF1R variant predicts breast cancer risk in women with preeclampsia in California Teachers Study. Cancer causes & control : CCC 2017 Aug . Powell Mark J, Von Behren Julie, Neuhausen Susan, Reynolds Peggy, Benz Christopher |
| Insulin-like growth factor 1 receptor expression and IGF1R 3129G?>?T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01). Breast cancer research : BCR 2016 18 (1): 3. de Groot Stefanie, Charehbili Ayoub, van Laarhoven Hanneke W M, Mooyaart Antien L, Dekker-Ensink N Geeske, van de Ven Saskia, Janssen Laura G M, Swen Jesse J, Smit Vincent T H B M, Heijns Joan B, Kessels Lonneke W, van der Straaten Tahar, Böhringer Stefan, Gelderblom Hans, van der Hoeven Jacobus J M, Guchelaar Henk-Jan, Pijl Hanno, Kroep Judith R, |
| Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen. The pharmacogenomics journal 2014 Feb 14 (1): 28-34. Winder T, Giamas G, Wilson P M, Zhang W, Yang D, Bohanes P, Ning Y, Gerger A, Stebbing J, Lenz H |
| Association of polymorphisms and haplotypes in the insulin-like growth factor 1 receptor (IGF1R) gene with the risk of breast cancer in Korean women. PloS one 2014 9 (1): e84532. Kang Han-Sung, Ahn Sei Hyun, Mishra Siddhartha Kumar, Hong Kyeong-Man, Lee Eun Sook, Shin Kyung Hwan, Ro Jungsil, Lee Keun Seok, Kim Mi Kyu |
| Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment. Endocrine-related cancer 2011 Oct 18 (5): 565-77. Drury S C, Detre S, Leary A, Salter J, Reis-Filho J, Barbashina V, Marchio C, Lopez-Knowles E, Ghazoui Z, Habben K, Arbogast S, Johnston S, Dowsett |
| Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC medical genomics 2010 3 (1): 9. Biong Margarethe, Gram Inger T, Brill Ilene, Johansen Fredrik, Solvang Hiroko K, Alnaes Grethe I G, Fagerheim Toril, Bremnes Yngve, Chanock Stephen J, Burdett Laurie, Yeager Meredith, Ursin Giske, Kristensen Vessela |
| Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast cancer research : BCR 2009 11 (5): R76. Neuhausen Susan L, Brummel Sean, Ding Yuan Chun, Singer Christian F, Pfeiler Georg, Lynch Henry T, Nathanson Katherine L, Rebbeck Timothy R, Garber Judy E, Couch Fergus, Weitzel Jeffrey, Narod Steven A, Ganz Patricia A, Daly Mary B, Godwin Andrew K, Isaacs Claudine, Olopade Olufunmilayo I, Tomlinson Gail, Rubinstein Wendy S, Tung Nadine, Blum Joanne L, Gillen Daniel |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 26, 2022
- Content source: